RecruitingPhase 2

Azithromycin for Meningococcal Carriage

United States1,120 participantsStarted 2024-11-12

Plain-language summary

The purpose of this study is to determine the effectiveness of azithromycin in the eradication of nasopharyngeal carriage of N. meningitidis

Who can participate

Age range18 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to provide their own informed consent and understand study procedures * Undergraduate and graduate students attending Emory University affiliated campuses who reside in university affiliated housing (for undergraduate/graduate) or in off-campus housing (undergraduates). Exclusion Criteria: * University faculty and staff * Currently pregnant or breast feeding * History of immediate or moderate-to-severe allergic reactions to azithromycin * Individuals who have taken systemic antibiotics for any reason in the 30 days prior to enrollment * Individuals with any symptoms of acute illness at the time of screening

What they're measuring

Eradication of N. meningitidis carriage

Timeframe: Day 7 (immediately prior to azithromycin administration), Day 21 (2 weeks after azithromycin administration)

Trial details

NCT IDNCT06618534

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05

Contact for this trial

Paulina Rebolledo, MD, MSc

404-251-8855 preboll@emory.edu

View on ClinicalTrials.gov More Meningococcal Infections trials